ArticleInternational journal of molecular sciences2025

The SGLT2 Inhibitor Dapagliflozin Disrupts the Cell Cycle at High Concentrations Without Altering Glycosphingolipid (De Novo)Biosynthesis.

Richard Jennemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.